COVID-19: Vaccines and Therapeutics

With spring in full bloom, AHA is offering for hospitals and health system a social media toolkit promoting COVID-19 vaccination and boosters.
NYC Health + Hospitals, which operates the public hospitals and clinics in New York City, announced plans to ensure New Yorkers continue to have the access to COVID-19 testing, vaccination, and treatment, as well as services to address Long COVID in all five boroughs.
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament season as a foundation for messages encouraging patients to stay up-to-date with their COVID-19 vaccinations.
The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months through 4 to receive a single booster dose at least two months after completing three Pfizer monovalent vaccine doses.
Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2 infection for at least four months, according to a study in those ages released yesterday by the Centers for Disease Control and Prevention.
As the respiratory illnesses spread, experts at WVU Medicine Children’s Hospital began to share vital information addressing the ‘tridemic,’ to help keep kids safe, avoid hospitalizations and lessen the burden on the health system.
AHA is offering for hospitals and health systems a second social media toolkit for February with messages for promoting COVID-19 vaccination and boosters.
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing pediatric illness from COVID-19, the flu and RSV.
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated and boosted against COVID-19 when eligible to protect themselves, their families and communities from serious disease and death.
When the omicron BA.4/BA.5 variants were circulating, Americans who received an updated COVID-19 vaccine were 14 times less likely to die than those who received no vaccine and five times less likely to die than those who received the original monovalent vaccine, according a study released today by…